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Abstract.  The glucocorticoid receptor (GR) is a 
ligand-regulated  transcription  factor that controls 
genes necessary to initiate glucocorticoid-induced 
thymocyte apoptosis.  We have performed a genetic 
analysis of thymocyte cell death by isolating and 
characterizing  a panel of GR  + dexamethasone-resistant 
mutants  of the murine WEHI7.2 thymocyte cell line. 
These apoptosis-defective (Apt-)  mutants  were used to 
identify previously unknown  early steps in the apop- 
totic pathway.  The Apt- mutants  contain  nonglucocorti- 
coid receptor,  recessive mutations  in genes that repre- 
sent multiple  complementation  groups.  These muta- 
tions block apoptosis induced by dexamethasone, 
gamma  irradiation,  and c-AMP treatment before the 
point where Bcl-2 exerts its protective effect. We pro- 
pose that different signals  share a  common apoptotic 
pathway, and that the induction of apoptosis involves 
multiple precommitment  steps that can be blocked by 
recessive mutations. 
OPTOSIS is  a  common,  cell  autonomous  process  in 
which a cell actively participates  to cause its own 
death in response to a variety of signals (14, 35, 38, 
59, 70). In mammals,  for example, apoptosis serves an im- 
portant role in the proper development and maintenance of 
the hematopoietic (36), immune (15, 26, 52), and neural sys- 
tems (33, 50).  The widespread occurrence of apoptosis in 
multicellular organisms suggests that it is an important bio- 
logical process. Recent findings underscore this idea by im- 
plicating the failure to initiate, or the inappropriate induction 
of apoptosis, in several pathological conditions (3,  11, 22). 
The active nature of apoptosis is illustrated by the series 
of sequential events that characterize this type of cell death. 
Apoptotic cells undergo a series of dramatic morphological 
changes  before loss of viability.  These include  chromatin 
aggregation,  nuclear  and  cytoplasmic  condensation,  and 
finally, fragmentation of the cell into small membrane bound 
apoptotic  bodies  that  can  contain  nuclear  fragments  and 
intact  organelles  (42,  70).  In  addition,  multiple  cellular 
responses can accompany morphological changes. These in- 
clude the induction of select genes (61),  changes  in cyto- 
plasmic  Ca  ++ levels (44,  48),  and degradation  of genomic 
DNA (1, 69). 
Numerous  signals  can  trigger  apoptosis  and  several  of 
these may be active in any given cell type. For example, im- 
mature routine thymocytes undergo apoptosis in response to 
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glucocorticoids (62) and T cell receptor (TCR)t stimulation 
(65).  More recently, it has become apparent that damaged 
or impaired cells can produce an apoptotic signal (11, 47). 
For instance,  damaging agents such as oxidative stress (8, 
31), low dose gamma irradiation (15), and some chemother- 
apeutic drugs (29) can cause thymocyte apoptosis. Less ob- 
vious types of damage, such as mutations that result in inap- 
propriate gene expression,  may also produce an apoptotic 
signal. For example, enforced expression of c-myc in serum- 
starved fibroblasts causes cell death (21). Similarly, elevated 
expression of the tumor-suppressor gene, p53, in proliferat- 
ing myeloid cells triggers apoptosis (71). 
While  multiple  stimuli  can trigger  apopt0sis,  there  are 
fewer known cellular antagonists of this process. An example 
is  Bcl-2,  identified  by  cloning  the  t[14:18]  chromosome 
translocation in follicular lymphoma (13), that developmen- 
tally blocks apoptosis in several cell types (30, 34, 63). In 
thymocytes, ectopic Bcl-2 expression also blocks apoptosis 
initiated by glucocorticoids, gamma irradiation, TCR stimu- 
lation (63, 67), and H202 (31).  This data suggests that Bcl-2 
antagonizes an event that is a common response to a variety 
of apoptotic triggers. Recent data has implicated the genera- 
tion of reactive oxygen species (31, 34) or calcium mobiliza- 
tion (39) as late events antagonized by Bcl-2. However, while 
early apoptotic signals, and late events antagonized by Bcl-2, 
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totic pathway that link the two have remained obscure. 
To investigate the mechanism controlling the induction 
of cell death, apoptosis-defective (Apt-) mutant cell lines 
were isolated and characterized in this study. We chose to 
investigate glucocorticoid-induced apoptosis in the murine 
cell line WEHI7.2 (W7.2), which is a tissue culture model 
for immature thymocytes  (15, 28). W7.2 cells have extremely 
low levels  of Bcl-2 (19, 39)  and undergo apoptosis in re- 
sponse not only to the synthetic glucocorticoid agonist, dexa- 
methasone (dex) (16), but also to cAMP analogs, H202, cal- 
cium ionophore (46),  and gamma irradiation (57).  The low 
incidence of spontaneous dex resistance  (<1  x  10  -~°) in 
W7.2 cells (19) provided a powerful means to clonally isolate 
dex-resistant  (dex9  mutants  after  chemical  mutagenesis. 
Furthermore, W7.2 cells are particularly useful for somatic 
cell genetic studies since they have a nearly normal diploid 
karyotype with a  stable mean chromosome number of 43. 
Biochemical and genetic analyses of the Apt- mutants have 
helped to clarify early steps in thymocyte  apoptosis and have 
led to a proposed model that describes a common apoptotic 
pathway. 
Materials and Methods 
Cell Culture and Reagents 
Cells were grown in DMEM (Irvine Scientific, Santa Ana, CA) containing 
10 % iron-supplemented, defined calf bovine serum (CBS, Hyclone Labs., 
Logan, UT),  100 U/ml penicillin, and 0.1  mg/ml streptomycin in an at- 
mospbere of 90%  humidity, 8%  CO2 at 37°C.  Isotonic phosphate (PD) 
buffer contained 136 mM NaCI, 2.6 mM KC1,  1.5 mM KH2PO4, and 8.1 
mM Na2HPO4. Isolation of clonal cell lines by soft agar cloning (17) in- 
eluded addition of the appropriate drugs where indicated.  The cell line 
Apt4.8 was designated W.408 in a previous publication (23). WG3 and WG5 
were grown in media containing 10% charcoal-stripped CBS. For all treat- 
ments used to induce apoptosis, a dose response experiment was done using 
W7.2 cells, and the lowest treatment level that caused cell death was used 
for all subsequent experiments. Growth curves were done by treating cells 
at a density of 105 to 3  x  los cells/aft, and using an hemocytometer to 
count viable cells by trypan blue (GIBCO BRL, Gaithersburg, MD) exclu- 
sion at various intervals. Dexamethasone (Sigma Chem. Co.,  St.  Louis, 
MO) was prepared as a 0.01-M stock dissolved in ethanol. 8-bromo-c-AMP 
(Alderidge) was dissolved in water at 200 mM and used at a final concentra- 
tion of 200/~M. Gamma irradiation was delivered from 6°Co source from 
an Atomic Energy of Canada Theratron 60 at variable dosage rates of 70-80 
rads/min. H202 and calcium ionophore A23187 (dissolved in DMSO at 
4.0 raM), were obtained from Sigma and used at a final concentration of 
100/zM and 1.5 #M, respectively. G418 (GIBCO BRL) was dissolved in 
0.1 M Hepes, pH 7.2, and active drug was used at a concentration of 1,000 
t~g/mi. Wright-Giemsa reagents were purchased from Sigma and were used 
as recommended. 5-Iodoacetamidofluorescen and 5-and-6-Iodoacetamido- 
tetra-methylrhodamine (Research Organics, Inc., Cleveland, OH) were dis- 
solved in DMSO as a 1-mg/ml stock. Gas chromatography grade PEG 4000 
was obtained from EM Science (Cherry Hill, NJ). 
Mutagenesis Protocol 
Cell cultures were grown to a  density of 2.5  x  los cells/ml and treated 
with 300-400 ~g/ml ethyl methanesulfonate (EMS) for 13 h which killed 
50% of treated cells. To isolate dex-resistant cell lines, EMS-treated cells 
(in some experiments cells were treated concurrently with 1/~M dex) were 
washed and allowed to recover in DMEM containing 10% CBS and antibi- 
otics for 2-3 d. These cells were then plated in soft agar media containing 
l/~M dex (G418 was added for WG3 and WG5 mntagenesis). Colonies were 
picked and expanded in DMEM containing 10% CBS, 106 M dex, and an- 
tibiotics. The origin of the mutants was as follows: Apt4.8 and Apt4.19 were 
derived W7.2 in separate experiments using 400/zg/ml EMS, Apt3.8 was 
also derived from W7.2 but 300/~g/ml EMS was used in the presence of 
dex. AptS.N mutants were all derived from WG5 using 400/~g/ml EMS; 
Apt5.8  and  AptS.26  were  isolated  from  the  same  experiment,  while 
AptS.45, AptS.60, and AptS.100 were isolated from three separate experi- 
ments. 
Dex Binding 
Routinely, 5  x  107 cells were harvested, washed once with PD buffer, fro- 
zen in liquid nitrogen, and stored at -80°C. Cell pellets were thawed on 
ice and 250/~1 ice cold TEGN50 (10 mM Tris-HC1, pH 7.5,  1 mM EDTA, 
10%  vol/vol glycerol,  1 mM 2-mercaptoethanol, 50 mM NaCI,  10 mM 
Na2MoO4, 1 mM PMSF) was immediately added. Each sample was soni- 
cared on an ice/H20 slurry and cleared by centrifugation in a 4°C micro- 
fuge at maximum  speed for 5 min. Triplicate-binding reactions were assem- 
bled  by adding  [3H]dex  (Amersham,  12.4  mM stock concentration)  to 
each tube (final concentration =  10 nM) which contained 65/~1 of cell ex- 
tract normalized for protein content. To measure nonspocific binding, unla- 
beled dex (final concentration =  10/~M) was added to one tube. The label- 
ing reactions were incubated on ice for 90 rain. To remove unbound ligand, 
100  ~tl of dextran-coated charcoal  suspension (10  mg/ml acid-activated 
charcoal and 1 mg/mi dextran in TEGN 50) was added to each tube and 
vortexed briefly.  The entire binding reaction was transferred into the top 
portion of a  0.45  #m Micro-Spin  Filter  (Lida  Manufacturing) and cen- 
trifuged at 50% maximum speed in an Eppendoff microfuge for 5 rain at 
room temperature. Bound [3Hldex in the charcoal-free filtrate was mea- 
sured in a scintillation counter (Beckman Instrs.). Net specific binding was 
calculated by subtracting the nonspecific binding from the average of the 
duplicate reaction tubes. 
Transient Heterokaryon Assay 
Cells were grown to a density of "~5  x  1OS/ml, harvested by centrifuga- 
tion, washed in isotonic PD buffer, and resuspended at 5  x  107 cells/ml 
in DMEM containing 0.5% CBS. Cells were labeled by addition of either 
5-Iodoacetamidofluorescen (final concentration =  0.075/zg/ml) or 5-and-6- 
Iodoacetamidotetra-methylrhodamine (final  concentration  =  1.0 /~g/ml) 
and incubated at 37°C for 30 min. Labeled cells were washed three times 
in 37°C serum-free DMEM to remove residual label and serum. At least 
109 cells of cach fusion partner were mixed in 37°C serum-free DMEM in 
a 50-ml Falcon tube, pelleted at 400 g, and the supernatant was completely 
removed by aspiration. The pellet was tapped to loosen the cells and 1.0 
ml of prewarmed (42"C) fusagen (45% PEG 4000, and 5% DMSO in PD 
buffer) was added dropwise over a period of I rain while swirling the tube. 
The tube was quickly transferred to a 42°C water bath and swirled for thirty 
seconds, and then placed in a tabletop centrifuge (prewarmed to 37°C) and 
spun for 10 s at 400 g (60 s total). Fused cells were then diluted dmpwise 
with 420C serum-free DMEM as follows: 1.0 ml in 30 s, 3.0 ml over 30 s, 
and 20 ml over 1 rain.  Cells were allowed to settle for 5  rain, and then 
spun at 400 g  for  10  rain and gently resuspended in 37°C  serum-free 
DMEM. This wash was repeated to remove residual PEG and the cells were 
resuspended at a density of 5  x  106 cells/ml in DMEM with 10%  serum, 
and allowed to recover for 2-4 h at 37"C. The cell suspension  was adjusted 
to 35 ml and la~yered over a  15-ml Ficoll-Paque gradient (Pharmacia LKB 
Biotechnology, Piscataway, NJ) and centrifuged at 500 g for 30 rain at 15"C. 
The live cells were removed from the interface, washed twice with 370C 
PD buffer, and brought to a final density of 3  x  106 cells/ml before sorting 
on a  FACStar instnanent (Beckman Instrs., FuUerton, CA).  Fused cells 
were sorted based on fluorescent emissions, forward, and side scatter in or- 
der to purify doubly labeled, large, and viable cells. Sorted double positive 
cells were concentrated by eentrifugation and suspended in DMEM con- 
taining 1.0% CBS 5:1/~M dex. These samples were then placed in an incu- 
bator and analyzed by microscopic examination at 1-, 3-, and 5-<1 intervals. 
The difference in viability between the control and dex-treated samples was 
determined by comparing the number of light fractile cells using a phase 
contrast microscope as described (16). 
Stable Transfectants 
DNA to be transfocted was linearized in the ~-lactamase gene with either 
Accl or Xrnnl restriction enzyme, phenol extracted, ethanol precipitated, 
and resuspended in water.  Cells were grown to a  density of 3-5  x  l0  s 
cells/ml, harvested by centrifugation, washed once with PD buffer, and 
resuspended at a density of 107 cells/ml in HBS buffer (21 mM Hepes, 137 
mM NaCl, 5 mM KC1, 0.7 mM Na2HPO4, 6 mM glucose). Equal amounts 
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Figure 1.  Sensitivity of W7.2, 
Hbl2 Apt3.8, Apt4.8, Apt4.19, 
and  AptS.8  cells  to  dex. 
Growth  curves  (A)  were  de- 
rived  from triplicate  cultures 
of cells grown in the absence 
(open  circle)  or  presence 
(closed circle)  of 0.1  /~M dex 
(vertical bars shows standard 
deviation).  Cell viability  was 
determined by trypan blue ex- 
clusion.  (B)  Representative 
fields  of trypan  blue-stained 
cells, exposed to dex for 3  d, 
and  photographed  through  a 
phase contrast microscope are 
shown. 
of linearized and supercoiled plasmid (100 #g total) were added to 1 ml of 
cell suspension in an electroporation cuvette. A BRL Cell Porater was used 
at a  setting of 1180 #F and 250 V  at room temperature. After a  10-min 
recovery period, the transfected cells were plated in DMEM containing 
10%  CBS, and antibiotics. To isolate stable transfectants, the transfected 
cells were plated in G418-containing media for 1-2 d before being plated 
in soft agar media containing G418. 
Northern blots 
Total RNA was isolated by guanidinium lysis followed by CsCI centrifuga- 
tion and 15/~g of  RNA/lane was subjected to Northern analysis as described 
(2). The Cam probe was an EcoRI-Pstl fragment from a chicken genomic" 
clone (56), the GST Ybl probe was a full-length cDNA cloned from rat (10), 
the Dag-8 probe was the 3' end ofa dex-induced  transcript cloned from W7.2 
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of W7.2 Derivatives  and Apt- Mutants 
Relative dex  Dex 
Cell line  binding  sensitive 
Wild-type  W7.2  1.0  yes 
cells  WG3  1.9  yes 
WG5  2.5  yes 
Mutant  Apt5.8  2.0  no 
cells  Apt4.8  1.0  no 
Apt3.8  1.0  no 
Apt4.19  1.0  no 
Apt3.2  0.7  no 
Apt3.6  0.5  no 
Apt3.80  0.1  no 
+GR eDNA Apt  Apt4.8G8  2.5  no 
cells  Apt3.8G3  2.0  no 
Apt4.19G5  2.0  no 
Apt3.2G2  1.9  yes 
Dex-binding values are the means of at least three separate experiments. Rela- 
tive values were obtained by the division of specific  dex-binding values for 
each cell line by the dex-binding value of W7.2. Dex sensitivity was evaluated 
by the ability  of cell lines to grow in the presence of 1.0/~M dex for a 4-d 
period. 
(Flomerfelt, E  A., and R. L. Miesfeid, manuscript in preparation), and the 
histone H3.3 probe used was an internal PCR fragment isolated from W7.2 
using H3.3-specifie primers  (55).  Probes  were  labeled  with  32padCTP 
using a random primer labeling kit (Promega Corp., Madison, WI) and hy- 
bridization was done at 42"C in a 50% formamide buffer (2). Blots were 
washed in buffer containing 0.1x SSC and 0.1% SDS at 65"C. Quantitation 
of transcript levels was done on a Phosphorimager and included normaliza- 
tion to mouse historic H3.3 expression levels (Molecular Dynamics, Sun- 
nyvale, CA). 
Microscopy 
False color fluorescent images were produced using a liquid cooled CCD 
camera (Photometrics) attached to an Olympus IMT-2 inverted microscope 
equipped with a 60×  1.4 NA Olympus objective. Standard optics for visual- 
ization of rhodamine and fluorescein fluorescence were used. The digitized 
image was processed on a Silicon Graphics Personal Iris computer. Trans- 
mitted light micrographs were obtained using standard techniques. Electron 
microscopy was carried out using established techniques (54). 
Results 
Isolation and Characterization of  Dex, Cell Lines 
EMS mutagenesis of dex-sensitive W7.2 cell lines, followed 
by selection for growth in 1 #M dex, resulted in an isolation 
of several hundred dex  r cell lines. Fig.  1 shows the effect of 
dex on the growth of W7.2 and representative dex  r cell lines 
Apt3.8,  Apt4.8, Apt4.19, and AptS.8 that were clonally iso- 
lated  from  four  separate  cultures  of  mutagenized  dex- 
sensitive cells (see Materials and Methods for parental ori- 
gins). As a population, the growth of W7.2 cells is slowed 
for 24 h in response to dex treatment. Individual apoptotic 
cells, as judged by morphology, are evident within 12 h of 
treatment (Figs. 1 B and 2) and increase in number as culture 
viability  is  lost.  In  comparison,  the  dex  r  mutant  Apt3.8 
showed only a slight decrease in growth rate in the presence 
of dex, while the growth of Apt4.8, Apt4.19, and Apt5.8 was 
unaffected by hormone. In addition, cultures of these cells 
retained a high level of viability for three days in dex (Fig. 
Table II. Frequency of Dex Resistance after EMS 
Mutugenesis  of Dex-sensitive  Cell Lines 
Cell line  # Mutagenized  # Dex resistant  # GR  +  % Apt- GR  + 
W7.2  109  90  3/90  <5 % 
WG3  3  x  109  22  14/22  =65% 
WG5  8.5  x  109  101  44/46  >95% 
GR content was determined as described by either, or combinations of, dex 
binding, dex-dependent transcriptional regulation of pMMCAT reporter plas- 
mid, or complementation of dex-dependent apoptosis when fused to Apt3.2 
cells. 
1 B) and could be maintained in media containing dex for 
several weeks (data not shown). 
For comparison, the growth of a W7.2 cell line that ex- 
presses human Bcl-2, Hbl2 (39), was examined under the 
same conditions. In agreement with previous results (39), 
Hbl2 cells remained viable for three days in dex. However, 
Hbl2 growth was slowed and some apoptotic cells were evi- 
dent by the third day (Fig.  1 B). 
Identification of  Dex" Mutants That Have a GR  ÷, 
Apt- Phenotype 
Since previous attempts to obtain dex  ~ thymocyte cell lines 
have often resulted in the isolation of glucocorticoid recep- 
tor (GR)  defective cells  (9,  64),  the dex  r cell lines  were 
screened for dex-binding and transcriptional regulatory ac- 
tivities  to  identify  apoptotic-defective  mutants  that  ex- 
pressed normal levels of functional GR. Table I shows the 
results of [3H]dex-binding assays that measured GR levels 
in  selected dex  r cell lines.  The majority of the dex  r cell 
lines  derived from W7.2  had  reduced  levels  of pH]dex 
binding (e.g., Apt3.2, Apt3.6, and Apt3.80). However, some 
cell lines (Apt4.8, Apt3.8,  Apt4.19, and Apt5.8) retained at 
least wild-type levels of [3H]dex-binding activity. Each of 
these mutants was tested for dex-dependent GR transcrip- 
tional regulatory activity by transient transfection of the GR- 
responsive reporter plasmid pMMCAT (18),  and displayed 
equal or greater levels of dex-dependent induction of CAT 
activity than that observed with W7.2 (data not shown). To- 
gether, these results indicated that Apt3.8,  Apt4.8, Apt4.19, 
and Apt5.8 have normal levels of functional GR,  are not 
affected by limiting ligand availability,  and do not express a 
dominant negative form of GR. 
To exclude the possibility that dex resistance was due to 
undetected  loss-of-function  GR  mutations,  selected  dex  r 
mutants were stably transfected with a GR eDNA expres- 
sion plasmid that coexpresses the bacterial neomycin gene 
(pRGRNeo) (18).  G418 resistant subclones of each mutant 
were isolated,  screened for increased pH]dex-binding ac- 
tivity, and those with the highest levels of dex binding were 
tested for dex-induced cell death (Table I). Stable expression 
of GR eDNA restored dex sensitivity to the Apt3.2 subclone 
Apt3.2G2.  This result indicated that the dex resistance of 
Apt3.2 was due to a GR deficiency. In contrast, subclones 
of Apt4.8,  Apt3.8,  and Apt4.19 (Apt4.8G8, Apt3.8G3, and 
Apt4.19G5, respectively), each contained at least twice the 
parental level of GR and maintained a dex  ~ phenotype (Ta- 
ble I). Therefore, Apt4.8, Apt3.8,  and Apt4.19 were desig- 
The Journal of Cell Biology, Volume 127,  1994  1732 Figure 2. Microscopic examination of dex- and 8-br-cAMP-treated W7.2 cells reveal an apoptotic morphology. Wright-Giemsa staining 
was done on W7.2 cells treated with dex for 12 h (A) or 8-br-cAMP for 72 h (B).  A sample of the same cells used in B was examined 
by electron microscopy (C). Condensed chromatin (A, B, and C) and apoptotic bodies (B) characteristic  of apoptosis  are indicated by 
the arrows shown in each photo. 
nated as Apt- mutants to denote a  dex  ~ phenotype due to 
mutations in non-GR loci. 
Frequency of the Apt- Phenotype Increases with GR 
Gene Copy Number 
Characterization of the 90 dex  r mutants derived from W7.2 
yielded only three cell lines that fit the criteria for the Apt- 
phenotype (Table II). We reasoned that mutagenesis of WT.2 
cells containing integrated copies of GR cDNA should de- 
crease the isolation of GR-deficient mutants since GR gene 
copy number was elevated. WG3 and WG5 are two cell lines 
that were constructed by stable transfection  of W7.2  with 
pRGRNeo. Both of these dex-sensitive cell lines contain in- 
creased levels of dex-binding activity relative to W7.2 cells 
(Table I), express GR cDNA specific transcripts,  and have 
increased  levels of GR transcriptional  regulatory  activity 
(data not shown). 
EMS mutagenesis of WG3 and WG5 resulted in the isola- 
tion of 22 and  101  additional dex  r mutants,  respectively. A 
summary  of  the  results  from  mutagenesis  studies  using 
W7.2, WG3, and WG5 is shown in Table II. Although '~10- 
fold fewer dex  r cell lines were isolated from mutagenized 
WG3 and WG5 cells as compared to W7.2, a large percent- 
age of these mutants expressed high levels of functional GR 
and was found to have the Apt- phenotype. As shown in Ta- 
ble II, over 95 % of WG5 mutants had an Apt- phenotype as 
compared to <5%  of W7.2 mutants.  The use of WG3 and 
WG5 cells for mutagenesis enabled us to isolate over 60 ad- 
ditional dex' cell lines that contained wild-type levels of GR 
and were apoptosis defective (Apt-). 
Apt- Mutants Are Cross-resistant to Diverse Inducers 
of Thymocyte Apoptosis 
The ability of Bcl-2 to block cell death induced by many 
types of signals suggests that although independent signaling 
pathways can trigger apoptosis, at least some later event must 
be  shared.  To  determine  whether  the  Apt-  mutations 
affected GR-specific or shared events, dex  r Apt- cell lines 
were tested for cross resistance to other inducers of apop- 
tosis. 
Although  8-bromo-cyclic AMP  (8-br-cAMP)  is  a  more 
effective inducer of cell death in W7.2 cells than other cAMP 
analogs, its effect is delayed when compared to dex treatment 
(Figs.  1 and 3).  Since it was unclear whether 8-br-cAMP- 
treated cells produced a classic apoptotic response, a mor- 
phological study was done. Fig. 2 compares the morphology 
of Wright-Giemsa-stalned W7.2 cells exposed to dex or 8-br- 
cAMP.  Apoptotic  W7.2  cells  are  evident  within  12  h  of 
dex treatment (Fig. 2 A) as illustrated by nuclear condensa- 
tion and margination (see arrow). Treatment of W7.2 ceils 
with 8-br-cAMP resulted in a similar morphology; both con- 
densed and marginated nuclei, as well as apoptotic bodies, 
were present (Fig. 2 B, see arrows). Moreover, nuclear con- 
densation (see arrow), as revealed by electron microscopic 
examination, confirmed that 8-br-cAMP-treated W7.2 cells 
underwent a characteristic apoptotic cell death (Fig. 2  C). 
Fig. 3 compares the growth of W7.2 cells and mutants af- 
ter treatment with 8-br-cAMP or gamma irradiation.  Con- 
sistent with the morphological evidence, 8-br-cAMP treat- 
ment  of W7.2  cells  resulted  in  a  24-h  period  of normal 
growth followed by a complete loss of W7.2 viability. In con- 
trast, all the Apt- mutants retained viability in the presence 
of 8-br-cAMP,  while  both Apt4.8  and  Apt4.19  cells con- 
tinued to grow normally. Although the growth of Apt3.8 and 
Apt5.8 was slowed after 48 h of treatment, culture viability 
of all the Apt- mutants shown in Fig. 3 could be maintained 
for several passages in the presence of 8-br-cAMP (data not 
shown).  This data clearly illustrated  that these Apt- cells 
were cross resistant to 8-br-cAMP and dex.  As a  positive 
control for a resistant phenotype, the response of Hbl2 cells 
to 8-br-cAMP was tested and was similar to that of Apt4.8. 
Exposure to a low dose of gamma irradiation resulted in 
a rapid loss of  viability in W7.2 cells. In comparison, Apt3.8, 
Apt4.8, Apt4.19, and Apt5.8 cells retained viability but were 
growth arrested after an identical irradiation treatment. The 
growth  response  and  viability of gamma irradiated  Hbl2 
resembled that of the Apt- mutants.  The response of these 
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Figure 3. Sensitivity of W7.2, 
Hbl2, Apt3.8, Apt4.8, Apt4.19, 
and Apt5.8 cells to 8-br-cAMP 
or gamma irradiation.  Cells 
were grown as  described  in 
Fig. 1 except treated with 200 
/~M  8-br-cAMP (solid  lines) 
or 500 rads ionizing radiation 
(dashed lines). The open sym- 
bols are  untreated cells  and 
the closed symbols are treated 
cells. 
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Figure 4. Sensitivity of W7.2, Hbt2, Apt3.8, Apt4.8, and Apt5.8 to 
H202 and calcium ionophore A23187. Cells were grown as de- 
scribed in Fig. 1 except in the presence of either 100/zM H202 (A) 
or 1.5 /~M A23187 (B). 
cells  illustrates  a  distinction  between  two  biological re- 
sponses to gamma irradiation, growth arrest, a p53-medi- 
ated response (37), and the induction of apoptosis.  In the 
Apt-  mutants,  gamma  irradiation-induced  growth  arrest 
appears to be unimpaired, while the mechanism controlling 
apoptosis induction is defective. The lack of cell death in the 
mutants after gamma irradiation allowed resumption of nor- 
mal growth rate within a week (data not shown), while simi- 
larly  treated  cultures  of W7.2  lost  viability within  72  h 
(Fig. 3). 
Free radical production has been implicated as a causal 
agent of apoptosis in response to gamma irradiation, and di- 
rect production of free radicals by H202 treatment causes 
apoptosis  (12,  31).  Fig.  4  A  shows  that  100  #M  H202 
caused W7.2 cells to die within 24 h of exposure. Similar 
treatment of the Apt- cell lines revealed that while Apt4.8 
cells were H202-sensitive,  as  evidenced by increased cell 
death and a  steady decrease in cell viability, Apt3.8  and 
Apt5.8 cells were resistant and continued to proliferate. Al- 
though  Bcl-2  protected  Hbl2  cells  against  H202-induced 
cell death, the growth of these cells was slowed relative to 
Apt3.8 and Apt5.8.  Together, our results indicate that H202 
treatment mimics  intracellular  changes  that  occur before 
apoptotic commitment. 
Intracellular calcium mobilization has been proposed to 
be an important step in thymocyte apoptosis (44, 48) and 
some studies suggest that oxidative stress may be a factor that 
modulates the magnitude of calcium fluxes (51, 60). Treat- 
ment of  W7.2 with the calcium ionophore A23187 (A23187) 
has been shown to induce cell death similar to that produced 
by dex (46). As shown in Fig. 4 B, 1.5 #M A23187 rapidly 
induced cell death in W7.2. The same treatment also killed 
Apt4.8, Apt3.8,  Apt5.8, and Hbl2 cells. Although Hbl2 and 
Apt- cells were less sensitive to A23187 than W7.2, there 
was a prolonged, steady decline of viable cells, followed by 
a  complete loss of viability within 7  d  (data not shown). 
These data show that the lethal effects of A23187 bypass the 
blocks imposed by Apt- mutations and Bcl-2. 
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pression  in  response  to  dex 
treatment  of  W7.2,  Hbl2, 
Apt3.8,  and  Apt4.8 cells. 
Northern analysis of 15 #g to- 
tal  RNA probed  with gluta- 
thione  S-transferase  (GST), 
Dag-8, calmodulin (Cam), or 
histone (H3.3) probes. Identi- 
cal  RNA  samples were sep- 
arated  on formaldehyde gels 
and  transferred  to  Duralon 
membranes  (Stratagene,  La 
Jolla, CA). The resulting blots 
were hybridized with the in- 
dicated  probes,  quantitated, 
stripped,  and  reprobed  with 
histone  H3.3 to  control  for 
loading differences. Quantita- 
tion  of transcript levels (nor- 
malized  to H3.3) was done and 
induction  values  are  shown 
relative to  the  signal at  the 
zero time point. 
Gene Expression Patterns in Dex-treated Apt- and 
Hbl2 Cells Differ 
Mutations that affect early steps of the apoptotic pathway 
could alter the expression pattern of gene transcripts that are 
normally upregulated in dex-treated W7.2 cells. In addition, 
comparison of dex-induced gene expression pattern of in- 
dividual  Apt- cells with Hbl2,  might allow placement of 
the Apt- blocks relative to the  step affected by Bcl-2.  To 
test these possibilities, the expression patterns of glutathione- 
S-transferase (GST) (23),  calmodulin (Cam)  (5,  20),  and 
Dag-8 (Flomerfelt, E  A., and R.  L. Miesfeld, manuscript 
in preparation) were examined in several Apt- mutants. Al- 
though the role of GST and Cam in thymocyte apoptosis is 
unknown,  their elevated expression in preapoptotic W7.2 
cells may be indicative of cell death~-associated  changes in 
redox and calcium homeostasis, respectively (20, 23). Dag-8 
was isolated by subtraction hybridization from dex-treated 
W7.2 cells,  and its function is also unknown (Flomerfelt, 
E  A.,  and R.  L.  Miesfeld, manuscript in preparation.) 
Fig. 5 shows the results of Northern analysis of RNA ob- 
tained from W7.2, Apt3.8,  Apt4.8, and Hb12 cells exposed 
to dex for 0,  12, and 24 h. Mouse histone H3.3 RNA levels 
were measured as an internal control. GST expression in- 
creased rapidly in both W7.2 and Hbl2 cells, but no changes 
in basal GST transcript levels were observed in Apt4.8 or 
Apt3.8 cells.  Identical results were found in  10 other Apt- 
cell lines including AptS.8  (data not shown).  Dag-8  RNA 
levels  increased  uniformly  in  W7.2,  Hbl2,  Apt4.8,  and 
Apt3.8 cells after dex treatment. This finding is consistent 
with Dag-8 being a dex-regulated GR target gene (either pri- 
mary or secondary) rather than a gene that responds to cellu- 
lar changes associated with apoptosis. Cam message was in- 
duced in dex-treated W7.2 as expected (5, 20). Interestingly, 
a similar induction of Cam transcripts was also seen in re- 
sponse to dex in both Apt3.8 and Hbl2 cells. In contrast, no 
change was observed in Cam RNA levels of most Apt- cell 
lines  including Apt4.8  and Apt5.8  (data not shown).  The 
CAM expression data suggested that Apt4.8 and Apt3.8 con- 
tain mutations that affect distinct pathway steps. 
Heterokaryon  Fusions Reveal Multiple Apt- 
Complementation  Groups 
Although  it  is  not  possible  to  perform  standard  genetic 
crosses with somatic cells, it is feasible to test for phenotypic 
complementation using cell fusion studies. Since stable syn- 
karyon  fusion  cell  lines  may  contain  incomplete  sets  of 
genomic material due to chromosome loss (6), a rapid tran- 
sient heterokaryon complementation assay  was developed 
that is similar to that previously used by others (4, 7, 66). 
This procedure entailed the production of doubly labeled, 
fluorescent heterokaryons by polyethylene glycol (PEG) fu- 
sion,  purification of heterokaryons using  fluorescent-acti- 
vated cell sorting (FACS), and determining the effects of dex 
on nondividing heterokaryon populations. 
Fig. 6 A shows the FACS analysis of a typical heterokaryon 
purification in which the sorted cell population was 96.4% 
double positive for fluorescein and rhodamine labels.  For- 
ward-  and  side-scatter analysis  showed that  the  purified, 
double-labeled heterokaryons were viable and  larger than 
nonfused cells (data not shown). Fig. 6 B shows micrographs 
of fluorescent unsorted- and sorted-fused cells. Fused cells 
contained only 0.2% double-labeled cells (see arrow in the 
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Figure 6. Production and purification of double-labeled heterokaryons. (A) FACS analysis of fusion procedure plotted as log fluorescence 
rhodamine (FL2) vs log fluorescence fluorescein (FL/) for nonfused and fused, sorted cell populations. The percentage of double-labeled 
cells was determined by the proportion  of cells found within the box as shown. (B) Microscopic examination of fused cell populations 
using false color imaging. Cells shown by arrow represent the minority of double-positive heterokaryons in an unsorted-fused population. 
After FACS purification,  most sorted ceils are double labeled as seen in the two panels labeled fluorescein and rhodamine that show a 
single field of cells. 
left panel of Fig.  6  B),  but after FACS  purification,  most 
cells were double labeled and greater than 95 % of the het- 
erokaryons contained just two nuclei.  Sorted heterokaryons 
were divided into two equal populations in media containing 
1% calf serum to retard cell division. Dex was added to one 
of these samples, and after five days, dex sensitivity was as- 
sayed by determining cell viability. A heterokaryon popula- 
tion was considered to be dex sensitive if the number of via- 
ble,  dex-treated  cells  was  less  than  10%  the  number  of 
untreated viable cells after 5 d. Photomicrographs, shown in 
Fig.  7 A, demonstrate that control homokaryon fusions of 
Apt3.2  and  Apt4.8  are  dex,  and  retain  viability,  whereas 
Apt3.2  x  Apt4.8 heterokaryons are dex sensitive (Fig. 7 B). 
These  results  led  to  the  following  conclusions:  (a)  that 
Apt4.8 contains sufficient levels of functional GR to induce 
apoptosis  when  fused  to  a  GR-deficient  cell  line  (i.e., 
Apt3.2), (b) that the mutation in Apt4.8 is recessive, and (c) 
that this assay provided a method to functionally test GR in 
recessive Apt- mutants. 
To determine whether the fusion assay could be used to 
detect  dominant  mutations,  Hbl2  and  several  Apt-  cell 
lines were fused to W7.2.  As shown in Table III, the muta- 
tions in Apt3.2, Apt3.8, Apt4.8, and Apt4.19 were recessive 
when  fused  to  W7.2.  Fusions  with  additional  Apt-  cell 
lines (data not shown) failed to identify any dominant mu- 
tants.  Importantly,  the  dex  r phenotype of Hbl2  cells  was 
dominant in the heterokaryon fusion assay, as expected based 
on the dominant activity of Bcl-2. 
Fig. 8 summarizes the results of complementation assays 
of eight different Apt- mutants.  The grid scores (dex sensi- 
tive; yes or no) are the result of at least three separate experi- 
ments using more than 5  x  1@ viable heterokaryons that 
were greater than 85 % double labeled.  Each of the mutant 
cell lines was first fused with Apt3.2 (group A, GR defective) 
to  functionally test for GR mutations.  Mutants  that com- 
plemented Apt3.2 were then tested in paired combinations. 
As shown in Fig. 8, heterokaryons produced by fusing Apt4.8 
and  Apt3.8  were  dex  sensitive.  This  data  functionally 
demonstrated that these cell lines define different,  non-GR 
complementation groups (groups B  and  C).  Likewise,  fu- 
sions of Apt5.8 to either Apt3.8 or Apt4.8 defined a third non- 
GR  complementation  group  (group  D).  Two  additional 
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karyon assays detect comple- 
mentation  between  Apt4.8 
(GR  +) and GR-defective Apt- 
3.2 cells. Differentially labeled 
cells  were  fused  and  homo- 
karyons (A) or heterokaryons 
(B) were purified and analyzed 
by  phase  microscopy.  Dex- 
treated homokaryons of either 
Apt4.8 or Apt3.2 retained via- 
bility  in the  presence  or ab- 
sence of dex for 5 d (A). Het- 
erokaryons produced by fusion 
between  Apt3.2  and  Apt4.8 
underwent dex-dependent cell 
death within 5 d (B). 
non-GR complementation groups, represented by the WG5- 
derived  Apt-  mutants,  Apt5.45  (group  E)  and  Apt5.60 
(group F), were also identified with this assay. Importantly, 
none of the cell lines tested belong to more than one com- 
plementation group suggesting that multiple apoptotic muta- 
tions in our panel of Apt- cell lines may be rare. Group C, 
which contains the most members includes Apt4.8, Apt4.19, 
and  two  WG5-derived  cell  lines,  Apt5.100  and  Apt5.26. 
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with W7.2 
Fusion  Cell line  Dex sensitive 
1  Apt3.2  x  W7.2  yes 
2  Apt4.8  x  W7.2  yes 
3  Apt3.8 x  W7.2  yes 
4  Apt4.19  x  W7.2  yes 
5  Hbl2  x  W7.2  no 
Criterion for dex sensitivity  was done as described  in Fig. 8. 
These group C Apt- mutants cannot be siblings since each 
was clonally isolated from independent mutagenesis experi- 
ments. 
Discussion 
Diverse Apoptotic Signals Use A Common Pathway 
In vertebrates, many types of signals can trigger apoptosis 
to remove unwanted or potentially harmful cells. Since vari- 
ous apoptotic signals (e.g., glucocorticoids and gamma ir- 
radiation) use specific, non-overlapping signal transduction 
pathways, they must converge on a set of common events that 
cause cell death.  Events that comprise the common apop- 
totic pathway are functionally distinct from those that are re- 
quired for transmission of a particular signal. For example, 
defects in the common apoptotic pathway should block apop- 
tosis induced by many different signals, while mutations in 
signal pathways  should only block apoptosis induced by a 
particular signal. What are the molecular characteristics of 
the pathway that coordinates diverse signals and initiates cell 
death when appropriate? It is possible that individual signal 
pathways converge at a common step that directly determines 
apoptotic commitment.  Alternatively, diverse signal path- 
ways may converge upstream of the final commitment point. 
In this case, apoptotic signals would lead to a shared set of 
events that precede the commitment step. 
To date, the only genetic evidence for a common apoptotic 
pathway in vertebrates has been supplied by genes, like Bcl-2, 
that  dominantly provide cross  resistance to a  number of 
apoptosis inducers (31,  63, 67). This data suggests that al- 
though apoptosis can be induced by signal-specific pathways, 
Bcl-2 defines a later, shared event. However, information re- 
garding  additional common precommitment events in the 
A 
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B  ^pta~  yes  no  Alm~  C 
C  Apt4~  yes  yes  no  Apt4.19  C 
C  Apt4.19  yes  yes  no  no  AptS.26 
C  ^pts~s  yes  yes  no  no  no 
C  l  AI~S.IO0  yes  yes  no  no  no 
D  AptS~  yes  yes  yes  yes  n.d. 
E  AptS.45  yes  yes  yes  n.d  n.d. 
F  AptS.~0  yes  yes  yes  n.d.  n.d. 
apoptotic pathway has been lacking. We have isolated a num- 
ber of recessive mutants that are cross-resistant to dex, 8-br- 
cAMP,  and  gamma  irradiation  (Table IV).  These mutant 
phenotypes contrast with previously identified mutants that 
block a signal- or tissue-specific pathway. For example, p53 
appears to be essential  for irradiation-induced thymocyte 
apoptosis (41) while the transcription factor, nur77, seems to 
be required for TCR-mediated cell death (40, 68). Functional 
disruption of either p53 or nur77 does not affect glucocorti- 
coid-induced apoptosis in thymocytes, a pathway that abso- 
lutely requires GR (17).  Conversely, the GR deficiency in 
Apt3.2 cells did not block apoptotic induction by gamma ir- 
radiation or 8-br-cAMP (data not shown). Therefore, the ob- 
served cross resistance of the Apt- mutants indicates that 
these cells contain mutations in specific gene products that 
are  required after the  point of signal  convergence in  the 
apoptotic pathway. 
The Common Apoptotic Pathway Contains 
Separate Events 
Currently, the only step that has been identified as part of a 
common apoptotic pathway is defined by Bcl-2. Character- 
ization  of the  Apt-  mutants  and  Hb12  identified  several 
phenotypic groups, based on differences in gene expression 
(Fig. 5) and cross resistance (Table IV), that were suggestive 
of  additional common apoptotic pathway steps. In particular, 
the  differential sensitivity to  H202  of Apt4.8  and  Apt3.8 
cells, coupled with the finding that dex-dependent Cam gene 
expression was upregulated in Apt3.8,  but not Apt4.8, indi- 
cated that  Apt3.8  and Apt4.8  have mutations  in  separate 
genetic  loci.  Furthermore,  although  Apt-  and  Hb12  cell 
lines shared common features of cross resistance, only I-Ib12 
cells responded to dex treatment by an increase in GST tran- 
script levels. To functionally test whether Apt3.8 and Apt4.8 
represent separate complementation groups, and to deter- 
mine whether the chemically induced Apt- mutations were 
dominant or recessive, a rapid transient heterokaryon com- 
plementation assay was used. 
Results  from the heterokaryon assay provided three in- 
sights into the Apt- phenotype: (a) Apt- cells contain suffi- 
cient GR to produce dex-sensitive heterokaryons when fused 
with Apt3.2;  (b) the Apt- mutations were recessive in fu- 
sions with W7.2 cells; and (c) the recessive mutations that 
block apoptosis in the Apt- cells tested define five non-GR 
complementation groups. Phenotypic differences in Apt4.8, 
C 
AptSA00  D 
no  Apt.5.8  E 
n.d.  no  AptS.~  [  F 
n.d.  yes  n.d.  [ AptS.¢,0 
n.d.  yes  yes  [  n.d. 
Figure 8. Summary of hetero- 
karyon  fusion  assays. Each 
grid represents the results of  at 
least three separate fusion ex- 
periments.  Positive  comple- 
mentation  was  scored  when 
the number of  cells in the dex- 
treated sample was less than 
10% that of  the untreated sam- 
ple at the end of a 5-d period. 
Uppercase letters represent the 
tentative assignment of com- 
plementation  groups  (n.d., 
not done). 
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Cell line 
Apoptotic  W7.2  Hb  12  Apt3.8  Apt4.8  Apt5.8 
inducer  (wild-type)  (Bcl-2+)  (Group B)  (Group C)  (Group D) 
dex  -  ++  ++  +++  +++ 
8-br-cAMP  -  + +  + +  + + +  + + 
g-irradiation  -  + +  + +  + +  + + 
H202  --  +  +  +  +  +  +  +  + 
A23187  -  +/-  +/-  +/-  +/- 
Scoring was based on the growth curves shown in Figs. 2 B, 3, and 4 as follows: -  denotes lack of resistance (fully sensitive); + denotes partial resistance; 
+ + denotes resistant and slowed growth; + + + denotes fully resistant with near normal growth. 
Apt3.8, and Apt5.8 (see Table IV) supported the assignation 
of these three cell lines to three different complementation 
groups.  This  data  suggests  that  the  mutations  in  Apt4.8, 
Apt3.8, and Apt5.8 define separate components of the com- 
mon apoptotic pathway in W7.2 cells that depend on active 
gene expression. Furthermore, our data excludes the possi- 
bility that apoptosis is blocked in these Apt- cell lines by 
dominant negative mutations or by dominantly acting pro- 
teins like Bcl-2. Complementation group C contained 50 % 
(4/8) of the Apt- mutants analyzed by the fusion assay and 
each of these cell lines was derived from independent muta- 
genesis experiments. One interpretation of the high recovery 
of group C  mutant alleles is that few genes are involved in 
the precommitment pathway. Alternatively, it is possible that 
the group C determinant is highly sensitive to mutagenesis 
or that group C mutants may be heterozygous for a defect in 
a rate-limiting gene required to induce apoptosis, similar to 
the  preponderance  of GR-defective dex  r mutants  in  W7.2 
and $49 cells ([16, 24] and Table II). However, since back- 
crossing and cis-trans tests are not possible with this  sys- 
tem, the genetic interpretations of these data are somewhat 
limited. 
A Model  for Apoptotic Pathway Transit 
Our investigation of the apoptotic pathway in murine thymo- 
cytes  has  led  to  the  functional  identification  of multiple 
events, defined by recessive mutations, that are required for 
apoptosis induction and are distinct from a later event that 
can be antagonized by Bcl-2. Fig. 9 shows a schematic model 
in which signal pathways initiated by alex, 8-br-cAMP, and 
gamma irradiation  converge upstream of the  Apt-  muta- 
tions to initiate a common apoptotic pathway. In addition, 
some  pathway  steps  can  be  bypassed by  either  H202  or 
calcium  ionophore A23187  treatment.  The  differences  in 
gene expression patterns between dex-treated W7.2, Apt3.8, 
Apt4.8, and Hbl2 indicate that apoptotic pathway transit may 
trigger an interdependent cascade of gene expression. The 
recessive mutation in Apt4.8 cells, which provides cross re- 
sistance to dex,  8-br-cAMP, and gamma irradiation,  is by- 
passed by H202  treatment (see Table IV).  This data indi- 
cates that the gene mutated in Apt4.8 must be expressed in 
W7.2 cells to undergo apoptosis in response to dex,  8-br- 
cAMP, and gamma irradiation but not to H202.  This idea is 
consistent with previous studies that have shown a require- 
ment for intact transcriptional  regulatory domains of GR 
(17), p53 (41, 71), c-myc  (21), and nur77 (68) to induce apop- 
tosis. 
Since  Apt4.8  (group  C)  is  H2Oz-sensitive,  and  anti- 
oxidants  block apoptosis (31),  H202  treatment appears to 
mimic intracellular changes that occur in a precommitment 
step to promote apoptosis. However, oxidative stress, pro- 
duced by H202 treatment, is not sufficient to induce apopto- 
sis in Apt3.8 and Apt5.8 cells (Fig. 4). One interpretation of 
this data is that gene products, missing or reduced in Apt3.8 
and Apt5.8 cells, respond to increased oxidative stress, and 
promote induction of apoptosis under this condition. Finally, 
since A23187  treatment was lethal to all the Apt- mutants 
and Hbl2,  changes in calcium localization appear to be a 
later step. A minimum threshold signal strength to overcome 
pathway barriers (represented by dashed lines in Fig.  9) is 
indicated  since lower concentrations of H202  and A23187 
Signal  Pre-commitment  steps 
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Figure 9. A model for dex-induced apoptosis in W7.2 cells. This 
model  proposes  that  dex-induced apoptosis  results  from transit 
through a defined genetic pathway that requires regulated gene ex- 
pression.  The temporal sequence of events is (1) reception  and 
transmission of the apoptotic signal; (2) transcriptional  regulation 
and threshold expression of specific genes; (3) changes in cellular 
homeostasis and specific gene product levels that meet conditions 
required for transit through a precommitment period that may be 
positively or negatively affected by additional factors; and (4) com- 
mitment to undergo apoptosis  followed by activation of effectors 
that bring about apoptotic cell death. In this model, accumulation 
of reactive oxygen species and calcium mobilization are involved 
at different steps.  ApI- mutations  block passage  through  early 
steps of the pathway, illustrated  by crosses,  while Bcl-2 blocks 
apoptosis by antagonizing a later step. 
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and II), are insufficient to induce apoptosis. 
This model proposes that commitment to undergo apop- 
totic cell death occurs when all the conditions required to in- 
duce apoptosis have been met (Fig. 9 A). Our results suggest 
that the recessive, Apt- mutations block transit through the 
precommitment phase (Fig. 9 B). We predict that the Apt- 
mutations affect genes that are specifically required for apop- 
tosis.  More specifically,  based on the H202 sensitivity of 
Apt4.8 compared to that of Apt5.8 and Apt3.8, we propose 
that the mutation in Apt4.8 affects an early pathway step. 
Furthermore, our data suggests  that the Apt3.8  mutation, 
which confers cross resistance to dex, gamma irradiation, 
8-br-cAMP,  and H202, affects a later event, before the step 
affected  by Bcl-2. Based on the dex-dependent GST and Cam 
gene expression patterns of Hb12 cells, we suggest that Bcl-2 
antagonizes a relatively late step that may define an irreversi- 
ble commitment point (Fig. 9 C). This data contrasts with 
recent reports that imply that Bcl-2 may block apoptosis by 
preventing oxidative damage (31, 34) or by blocking calcium 
mobilization to the cytoplasm (39).  However, it is not clear 
whether these are primary effects of Bcl-2 expression (31), 
or  whether  these  effects  are  due  to  normal  repair  and 
homeostatic mechanisms that remain active in non-apoptotic 
cells. 
The striking observation that Bcl-2 protects against such 
a wide variety of apoptotic inducers also supports the notion 
that the dominant activity of Bcl-2 functions downstream of 
putative effector molecules (32).  Since all of the Apt- cell 
lines we tested were cross-resistant to dex, 8-br-cAME and 
gamma irradiation, we suggest that multiple common pre- 
commitment steps, which may provide a mechanism to coor- 
dinate regulatory inputs (i.e., cell death checkpoints), are 
used by diverse apoptotic signals. This idea could be ex- 
tended to propose that Apt- mutations define shared steps 
in a common pathway, rather than identifying  individual com- 
ponents of multiple parallel pathways. However, distinguish- 
ing between shared and parallel pathways will require more 
information of the genes defined by the Apt- mutations. 
A Genetic Model of Vertebrate Apoptosis 
One of the major goals of this work was to provide a cell cul- 
ture model to further investigate the induction of apoptosis 
in a vertebrate system. Although C. elegans provided a good 
invertebrate system, differences in its cell death program 
when compared to vertebrate apoptosis, and the inability to 
carry out detailed biochemical studies, limit its usefulness. 
To address this problem, W7.2 cells were used to generate 
a  panel  of  apoptosis-defective  mutants  that  provided  a 
genetic system to study thymocyte apoptosis. 
Phenotypic characterization of the Apt- cell lines indi- 
cates that they contain mutations that block apoptosis in re- 
sponse to a  variety of signals.  Although the identity and 
function of the mutated genes are unknown, our studies indi- 
cate that they define a  previously unknown group of cell 
death genes with novel characteristics. The Apt- cells pro- 
vide the first example of recessive mutations in vertebrates 
that result in cross resistance to multiple apoptotic inducers. 
This finding functionally distinguishes the recessive W7.2 
Apt- mutants from cell lines that express genes like Bcl-2 
that dominantly suppress cell death (see Table III, and [58]). 
Furthermore, it is unlikely that any Apt- mutants contain 
loss of function mutations in Bax, a protein that binds to and 
inactivates Bcl-2  (49),  since W7.2 cells contain negligible 
levels  of Bcl-2  protein and none of the Apt- mutants ex- 
hibited a dex-dependent increase in GST transcripts charac- 
teristic of Bcl-2-protected Hbl2 cells (Fig. 5). 
Some  putative  vertebrate  cell  death  genes  can  induce 
apoptosis through dysregulated expression. Two such exam- 
ples are the multifunctional c-myc  protein, that under special 
conditions can promote cell death (43), and the recently de- 
scribed protease, interleukin-1/~-converting  enzyme (ICE), 
which has homology to ced3 (45, 72). At this point, however, 
it has been difficult to discern cause from effect since ectopic 
expression of these proteins may result in aberrant cellular 
conditions that create apoptotic signals by default. For exam- 
ple, overexpression of the murine ced3 homologue, ICE, can 
induce apoptosis in RAT-1 cells (45).  However, no ICE tran- 
scripts were detected by Northern analysis of W7.2 cells 
treated with dex for 0, 6, 12, or 24 h using a full-length ICE 
cDNA probe (Flomerfelt, E A., and R. L. Miesfeld, unpub- 
lished  data).  This  finding  underscores  the  problem  in 
differentiating between gene products that can produce an 
apoptotic signal in certain cases, from those that are required 
to promote apoptosis. The Apt- mutants provide a system 
that should resolve some of these problems. 
A cell line system, such as W7.2, permits detailed bio- 
chemical analysis and facilitates the use of molecular tech- 
niques  that can  be  used  to  further  study apoptosis.  For 
example,  biochemical characterization of W7.2  and Apt- 
mutants can be done to quantify the role of changes in reac- 
tive oxygen levels  and calcium mobilization in apoptosis. 
Additionally, the Apt- cells may also provide a useful for- 
mat to test drug-induced therapeutic induction of apoptosis. 
Strategies  to  functionally clone  genomic  DNA  by  com- 
plementation of individual Apt- mutant cell lines may be 
possible since W7.2 cells require 18-24 h of dex treatment 
to commit a population to undergo apoptosis (19). For in- 
stance, FACS purification, or Ara C selection, could be used 
within this period to isolate transfected cells that undergo 
dex-dependent growth arrest. The goal of this approach, and 
other  strategies under  consideration, would be  to  rescue 
transfected mutants that regain hormone-dependent induc- 
tion of apoptosis. Finally, the Apt- mutants offer a method 
to systematically evaluate the role of genes in apoptosis that 
have been cloned by virtue of their differential expression in 
apoptotic cells (5, 25, 27, 53). 
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